The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Open accessAbstract
Metabolic reprogramming by oncogenic signals promotes cancer initiation and progression. The oncogene KRAS and tumour suppressor STK11, which encodes the kinase LKB1, regulate metabolism and are frequently mutated in non-small-cell lung cancer (NSCLC). Concurrent occurrence of oncogenic KRAS and loss of LKB1 (KL) in cells specifies aggressive oncological behaviour. Here we show that human KL cells and tumours share metabolomic signatures of perturbed nitrogen handling. KL cells express the urea cycle enzyme carbamoyl phosphate synthetase-1 (CPS1), which produces carbamoyl phosphate in the mitochondria from ammonia and bicarbonate, initiating nitrogen disposal. Transcription of CPS1 is suppressed by LKB1 through AMPK, and CPS1 expression correlates inversely with LKB1 in human NSCLC. Silencing CPS1 in KL cells induces cell death and reduces tumour growth. Notably, cell death results from pyrimidine depletion rather than ammonia toxicity, as CPS1 enables an unconventional pathway of nitrogen flow from ammonia into pyrimidines. CPS1 loss reduces the pyrimidine to purine ratio, compromises S-phase progression and induces DNA-polymerase stalling and DNA damage. Exogenous pyrimidines reverse DNA damage and rescue growth. The data indicate that the KL oncological genotype imposes a metabolic vulnerability related to a dependence on a cross-compartmental pathway of pyrimidine metabolism in an aggressive subset of NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“KRAS/LKB1-null lung cancer cells are more reliant on the urea cycle enzyme carbamoyl phosphate synthetase-1 (CPS1) for pyrimidine biosynthesis, although this dependency is independent of mTOR signaling (Kim et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Kim et al., 2017
In the citing paper
“Interestingly, the first step in de novo pyrimidine biosynthesis mediated by CPSs occurs mainly in mitochondria via CPS1 in K-Ras/LKB1-mutant lung cancer cells32 (Fig. 2).”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [32]
In the citing paper
“Although cytosolic CPS2 can produce a cytosolic pool of carbamoyl phosphate, CPS1 is a major rate-limiting enzyme in pyrimidine biosynthesis using nitrogen released via mitochondrial glutaminolysis32.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [32]
In the citing paper
“Furthermore, KL NSCLC cells exhibit increased dependence on dTTP synthesis and rely on an unorthodox pathway of pyrimidine biosynthesis that utilizes mitochondrially generated carbamoyl phosphate88, 89.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
LKB1 modulates lung cancer differentiation and metastasis
Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064
Jackson, D., & Pombo, A. (1998) · Journal of Cell Biology · doi:10.1083/jcb.140.6.1285 · Cited by 881
Petermann, E., Orta, M. L., Issaeva, N., Schultz, N., & Helleday, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.021 · Cited by 815
INTERACTIONS BETWEEN DEOXYRIBONUCLEOTIDE AND DNA SYNTHESIS
Reichard, P. A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002025 · Cited by 773
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 333
The emerging roles of the urea cycle in tumor microenvironment and therapies
Zhou, J., Sun, X., & Jiang, P. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.007 · Cited by 9
Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy
Du, F., Xiao, L., Guojun, W., Dai, Q., Li, J., Zhao, X., Zhang, Q., Yang, L., Liu, Y., Hu, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643017 · Cited by 9
p53 inhibits the Urea cycle and represses polyamine biosynthesis in glioma cell lines
Zhao, Y., Chen, Y., Wei, L., Ran, J., Wang, K., Zhu, S., & Liu, Q. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01173-y · Cited by 9
Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma
Wang, G., Bie, F., Qu, X. H., Yang, X., Liu, S., Wang, Y., Huang, C., Wang, K., & Du, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-31592-2 · Cited by 9
Li, W. X., Zhang, W., Deng, W., Zhong, Y., Zhang, Y., Peng, Z., Chen, H., Sun, R., Zhang, X., & Yang, S. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12839 · Cited by 9
Huang, S., Jiang, Y.-F., Yang, L., Yang, J., Liang, M.-T., Zhou, H., Luo, J. M., Yang, D., Mo, W., Chen, G., et al. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.3657 · Cited by 9
Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1
Rolfe, A., Yao, S., Nguyen, T.-V., Omoto, K., Colombo, F., Virrankoski, M., Vaillancourt, F. H., Yu, L., Cook, A. S., Reynolds, D. J., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00145 · Cited by 9
Matschke, J., Larafa, S., & Jendrossek, V. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200866 · Cited by 8
Makris, G., Kayhan, S., Kreuzer, M., Rüfenacht, V., Faccin, E., Underhaug, J., Díez‐Fernández, C., Knobel, P. A., Poms, M., Gougeard, N., et al. (2023) · 癌症:英文版 · doi:10.1002/cac2.12402 · Cited by 8
Shen, J. X., Sun, N., Wang, J., Zens, P., Kunzke, T., Buck, A., Prade, V. M., Wang, Q., Feuchtinger, A., Hu, R., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c11161 · Cited by 8
Loss of keratin 23 enhances growth inhibitory effect of melatonin in gastric cancer
Li, L., Meifang, L., Luo, J., Sun, H., Zhang, Z., Lin, D., Chen, L., Feng, S., Lin, X., Zhou, R., et al. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13145 · Cited by 8
A TRUSTED targeted mass spectrometry assay for pan-herpesvirus protein detection
Kennedy, M. A., Tyl, M. D., Betsinger, C. N., Federspiel, J. D., Sheng, X., Arbuckle, J. H., Kristie, T. M., & Cristea, I. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110810 · Cited by 9
Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics
Alur, V. C., Raju, V., Vastrad, B. M., & Vastrad, C. M. (2019) · Diagnostics · doi:10.3390/diagnostics9020039 · Cited by 8
Oncogenic Control of MetabolismPreprint
Pavlova, N. N., & Thompson, C. B. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041531 · Cited by 9
The emerging roles of glutamine amidotransferases in metabolism and immune defense
Xie, T., Qin, C., Savas, A. C., Yeh, W. W., & Feng, P. (2024) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2024.2351135 · Cited by 8
Unraveling the immune mechanisms and therapeutic targets in lung adenosquamous transformation
Xu, H., Yang, Y., Wang, P., Lin, S., Zhang, X., Ni, H., & Xu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1542526 · Cited by 8
Ming, Z., Luo, T., Zou, Z., Luo, W., Hu, X., Chen, L., Zhou, J., Liu, X., Mingquan, L., Li, J., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000769 · Cited by 7
Yao, Y., Luo, Y., Wang, Z., Yin, E., Liu, C., Zheng, S., Wang, X., Tang, X., Sun, N., & He, J. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012710 · Cited by 10
The impact of metabolic reprogramming in hepatocellular carcinoma on T cell
Liao, D., An, X., Huang, G., & Yuan, T.-L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1696113 · Cited by 9
Small molecule inhibitors for cancer metabolism: promising prospects to be explored
Liu, D., Wang, H., Li, X., Liu, J., Zhang, Y., & Hu, J. Y. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04501-4 · Cited by 7
del Caño‐Ochoa, F., & Ramón‐Maiques, S. (2020) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2019.1706743 · Cited by 7
Zhou, L., Wang, Q., Mao, L., Chen, S., Yang, Z., Liu, X., Gao, Y., Li, X., Zhou, Z., & He, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.875324 · Cited by 7
Metabolic Frugality Marks Cancer Cells for Immune Targeting
Sullivan, L. B. (2018) · Cell · doi:10.1016/j.cell.2018.08.023 · Cited by 7
Girardi, E., Fiume, G., Goldmann, U., Sin, C., Müller, F., Lindinger, S., Sedlyarov, V., Srndic, I., Agerer, B., Kartnig, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.275818 · Cited by 7
Dong, Y., Liu, W., Cheng, J., Li, Y., Huang, Y., Zheng, C., Lin, Z., & Pan, R. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157132 · Cited by 6
Impaired nitrogenous waste clearance promotes hepatocellular carcinoma
Han, X., Shen, J., Yan, J., Tacke, R., Dai, W., Mao, Q., Queen, H., Liu, S., Islam, A., Liu, T., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec0766 · Cited by 7
Sang, Y., Luo, C., Huang, B.-T., Wu, S., Shu, J., Lan, C.-G., & Zhang, F. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07081-y · Cited by 6
The Possible Roles of Glucosamine-6-Phosphate Deaminases in Ammonium Metabolism in Cancer
Lara‐Lemus, R., Castillejos-López, M. D. J., & Aquino‐Gálvez, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212054 · Cited by 6
Metabolic control of cancer progression as novel targets for therapy
Talukdar, S., Emdad, L., Gogna, R., Das, S. K., & Fisher, P. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.06.002 · Cited by 6
A subset of VEGFR‐TKIs activates AMPK in LKB1 ‐mutant lung cancer
Yang, L., Zhang, Q., Xiong, Y., Dang, Z., Xiao, H., Chen, Q., Dai, X., Zhang, L., Zhu, J., Wang, D., et al. (2022) · Cancer Science · doi:10.1111/cas.15677 · Cited by 5
Liu, F., Wu, Y., Zhang, B., Yang, S., Shang, K., Li, J., Zhang, P., Deng, W., Chen, L., Zheng, L., et al. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002816 · Cited by 6
Gao, Y., Gong, Y., Liu, Y., Xue, Y., Zheng, K., Guo, Y., Hao, L., Peng, Q., & Shi, X. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2022.151987 · Cited by 6
Regenerating liver uses ammonia to support de novo pyrimidine synthesis and cell proliferation
Endaya, B., Kučera, L., Le, D. T., Spinelli, J. B., Brožková, A., Luptáková, D., Klíma, K., Oliveira, G. L., Brisudová, P., Boháčová, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65451-2 · Cited by 5
Caldovic, L., Ahn, J. J., Andricovic, J., Balick, V., Brayer, M., Chansky, P. A., Dawson, T., Edwards, A. C., Felsen, S. E., Ismat, K., et al. (2023) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12687 · Cited by 4
Ye, Y.-H. (2024) · American Journal of Cancer Research · doi:10.62347/nxaj9418 · Cited by 5
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Yang, S., Lin, M., Hao, S., Ye, H., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1497461 · Cited by 5
Xu, Y., Chen, Y., Zhang, J., Wang, J., Yang, S., Zhao, H., Wu, L., Lei, J., Zhou, Y., Peng, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202411888 · Cited by 5
Ji, F., Huang, P., Zhou, Q., Ko, L. H., Wei, Q., Chan, C. C.-L., Chen, D. M., Chen, H., Kang, W., Cheung, A. H.-K., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.01.007 · Cited by 4
Zhang, Y.-P., Wu, F.-F., Wu, Z.-N., Li, Y., Chen, J.-Q., Cai, X.-T., Quan, X.-Y., Rong, Z.-X., Guo, Z.-Q., Duan, Z., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.02.052 · Cited by 4
Acquired resistance of cancer therapies: Mechanisms and perspectives
Wang, M., Zhai, X., Li, J., Chen, J., Gai, X., Liu, X., Liu, Y., Zhou, Q., & Chen, C. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004048 · Cited by 5
Yu, Y., Cen, C., Shao, Z., Wang, C., Wang, Y., Miao, Z., Sun, M., Wang, C., Xu, Q., Liang, K., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112275 · Cited by 4
Xiao, L., Li, Q., Huang, Y., Fan, Z., Ma, L., Liu, B., & Yuan, X. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/7651758 · Cited by 4
Zhao, M., Yuan, D., Wei, M., Zhang, J., Yang, W., Qin, S., & Li, L. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110677 · Cited by 3
Febres‐Aldana, C. A., Vanderbilt, C., Aly, R. G. M., Saliba, M., Seshan, S. V., Frosina, D., Jungbluth, A. A., Richards, A. L., Bodd, F. M., Wilson, C., et al. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.100965 · Cited by 4
Ong, K. H., Hsieh, Y., Sun, D., Huang, S. K., Tian, Y., Chou, C., Shiue, Y., Joseph, K., & Chang, I. (2023) · Diagnostics · doi:10.3390/diagnostics13132296 · Cited by 3
Zhou, R., Ma, H., Liu, Y., Chen, X., Chang, X., Chen, Y., Liu, L., Li, Y., Zhu, Y.-J., & Zhang, H.-B. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221102872 · Cited by 3
Markitantova, Y. V., Fokin, A., Boguslavsky, D. V., Simirskii, V. N., & Куликов, А. М. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316940 · Cited by 3
Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
Sitthideatphaiboon, P., Nantavithya, C., Chantranuwat, P., Vinayanuwattikun, C., & Sriuranpong, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-55476-w · Cited by 3
Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers
Huffman, K. E., Li, L. S., Carstens, R. M., Park, H., Girard, L., Avila, K., Wei, S., Kollipara, R. K., Timmons, B. C., Sudderth, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1025443 · Cited by 4
Self-citationHyper expression of MTBP may be an adverse signal for the survival of some malignant tumors
Mao, Y., Tian, M., Pan, B., Zhu, Q., Li, P., Liu, H., Liu, W., Dai, N., Yu, L., & Tian, Y. (2018) · Medicine · doi:10.1097/md.0000000000012021 · Cited by 3
Kim, J., Cai, F., Ko, B., Yang, C., Lee, H. M., Muhammad, N., Li, K., Haloul, M., Gu, W., Faubert, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.13.039669 · Cited by 3
Self-citationLiu, J.-F., Wu, S., Liu, C., Chen, H., & Yang, J. (2020) · Research Square · doi:10.21203/rs.3.rs-104808/v1 · Cited by 3
Metabolic Reprogramming in Cancer
Prusty, D., & Manna, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch25 · Cited by 3
Elevated arginine levels in liver tumors promote metabolic reprogramming and tumor growthPreprint
Mossmann, D., Park, S., Ryback, B. M., Weißenberger, D., Colombi, M., Hindupur, S. K., Dazert, E., Coto‐Llerena, M., Caner, E., Cenzano, V. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.26.489545 · Cited by 3
Malvi, P., Bugide, S., Dutta, R. K., Reddi, K. K., Edwards, Y. J. K., Singh, K., Gupta, R., & Wajapeyee, N. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102356 · Cited by 4
FOXO1 links KRAS G12D and G12V alleles to glutamine and nitrogen metabolism in colorectal cancer
Ber, S., Yang, M. H., Sciacovelli, M., Samarajiwa, S., Patel, K., Nikitopoulou, E., Howitt, A., Cook, S. J., Venkitaraman, A. R., Frezza, C., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00641-z · Cited by 2
Ammonia in cancer: dual roles and therapeutic strategies
Wei, J., Chen, Y., Li, Q., Huang, F., Zhang, C., Hou, B., & Huang, S. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04065-6 · Cited by 2
del Caño‐Ochoa, F., Rubio‐del‐Campo, A., & Ramón‐Maiques, S. (2023) · Molecules · doi:10.3390/molecules28020660 · Cited by 2
Metabolic pathway analysis of tumors using stable isotopes
Bi, Q., Zhao, J., Nie, J. H., & Huang, F. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.002 · Cited by 3
In Situ Quantification of Ammonia in Biofluids using High-Resolution Nuclear Magnetic Resonance
Xu, L., Chen, Y., Zhang, X., & Su, X. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00887 · Cited by 2
The differential regulation of the urea cycle in tumors goes awry
Abou‐Shanab, A. M., Khedr, M. A., & Matosevic, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117365 · Cited by 3
Zhang, X., Fong, J. J., Wang, Y., Kong, Y., & Zhou, J. (2024) · Environmental Engineering Science · doi:10.1089/ees.2024.0183 · Cited by 1
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice
Savani, M. R., Li, B., Smith, B. C., Gu, W., Xiao, Y., Baquer, G., Shipman, T. E., Oken, S., Manoj, N., Zacharias, L. G., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01520-0 · Cited by 4
Self-citationGe, Y., Sun, A., Yu, T., Yu, S., & Lu, K. (2025) · PeerJ · doi:10.7717/peerj.20262 · Cited by 1
Wang, Y., Wang, S., Yan, X., Li, X., Cheng, C., Geng, S., Chen, B., Du, H., Wang, Q., & Zhang, X. (2026) · Food Microbiology · doi:10.1016/j.fm.2026.105054 · Cited by 1
Self-citationMitochondria in sarcoma and carcinoma: Achilles’ heel or Hercules’ strength?
Ashrafi, M. R., Cayrefourcq, L., Rajabi, S., & Alix‐Panabières, C. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.03.004 · Cited by 1
Reprogramming of nitrogen metabolism in tumors: mechanisms and therapeutic implications
Fang, J., Ling, J., Liu, X., Wang, Y., Huang, Y., Cao, Z., 邹燕梅, & Xiong, H. (2026) · Amino Acids · doi:10.1007/s00726-026-03517-1 · Cited by 1
Bioengineered systems to exploit tumor microenvironment metabolism
Sanganoo, C., Caturegli, I., Mattes, Z. F., Ryan, J., Wong, W. W., & Grinstaff, M. W. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.04.003 · Cited by 1
Mi, W., Xia, X., Xue, Y., Li, L., Yang, L., Yang, X., Xu, J., Cai, X., Zhou, Y., Zhu, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117487 · Cited by 1
Self-citationYan, P., Jiang, W., Xue, X., Hou, T., Wang, J., Huang, D., Chen, L., Inuzuka, H., Dai, X., & Wei, W. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218678 · Cited by 1
Dynamic control of nucleotide metabolism in physiology and disease
Kim, D., & Hoxhaj, G. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02004-9 · Cited by 1
Pan, Z., Wong, M.-K., Lu, Y., Mao, J., Wang, F., Gu, X., Huang, K., Shi, T., Wu, T. W., Zhu, Y., et al. (2026) · Cell · doi:10.1016/j.cell.2026.09.040 · Cited by 1
Yang, C., Hu, L., Huang, Z., Deng, L., Guo, W., Liu, S., Xiao, X., Yang, H., Lin, J., Sun, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260720 · Cited by 1
Lung Cancer Variants in Romanian Population – a Genome-Wide Association Study
Bălan, A. M., Dugăeşescu, M., Bejan, I., Brîndușe, O., Bonciu, S., Ferdoschi, C., Iacob, D. G., & Poenaru, E. (2021) · E-Health and Bioengineering Conference (EHB) · doi:10.1109/ehb52898.2021.9657582 · Cited by 1
Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma
Zhou, W., Cheng, Y., Li, L., Zhang, H., Li, X., Chang, R., Xiao, X., Lu, L., Yi, B., Gao, Y., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030482 · Cited by 1
Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinomaPreprint
Stein, B. D., Ferrarone, J. R., Gardner, E. E., Chang, J. W., Wu, D., Chen, Q., Hollstein, P. E., Yuan, M., Liang, R. J., Coukos, J. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.01.462764 · Cited by 1
Sarlak, S. (2021) · theses.fr (ABES) · doi:10.70675/2e2c5420z3a1fz49c3zb548z8e72b24a52b2 · Cited by 1
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Hamada, H., & Tanuma, S. (2018) · InTech eBooks · doi:10.5772/intechopen.71095
Integrated Molecular Characterization of Lung Adenocarcinoma with Implications for Immunotherapy
Gimbrone, N. T. (2019) · Digital Commons - University of South Florida (University of South Florida)
It’s Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?
Caiola, E., & Broggini, M. (2020) · Cancers · doi:10.3390/cancers12113223
Exploiting Amino Acid Catabolism as a Metabolic Vulnerability in Breast Cancer
Geck, R. C. (2020) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.26.457847
Self-citationThe roles and mechanisms of urea cycle enzymes in tumor
Wei, M., Rui, Q. I. A. O., Zhang, J., Zhang, X., JiaXin, Y. U., & Li, L. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0436
DNA Methylation Diagnosis Markers Detection on Lung Adenocarcinoma with Deep LearningPreprint
Yuan, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1653074/v1
Priya, R. (2022) · International Journal of Clinicopathological Correlation · doi:10.56501/intjclinicopatholcorrel.v6i2.536
Stein, B. D., Ferrarone, J. R., Gardner, E. E., Chang, J. W., Wu, D., Hollstein, P. E., Liang, R. J., Yuan, M., Chen, Q., Coukos, J. S., et al. (2023) · doi:10.1158/2159-8290.c.6534613.v1
Stein, B. D., Ferrarone, J. R., Gardner, E. E., Chang, J. W., Wu, D., Hollstein, P. E., Liang, R. J., Yuan, M., Chen, Q., Coukos, J. S., et al. (2023) · doi:10.1158/2159-8290.c.6534613.v2
Fan, H., Xu, Z., Yao, K., Zheng, B., Zhang, Y., Wang, X., Zhang, T., Li, X., Hu, H., Yue, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.15.553338
Self-citationZheng, T., Huang, J., Xiang, X., Li, S., Yu, J., Qu, K., Xu, Z., Han, P., Dong, Z., Liu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16800377
Zheng, T., Huang, J., Xiang, X., Li, S., Yu, J., Qu, K., Xu, Z., Han, P., Dong, Z., Liu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16800380
Zheng, T., Huang, J., Xiang, X., Li, S., Yu, J., Qu, K., Xu, Z., Han, P., Dong, Z., Liu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16800386
Zheng, T., Huang, J., Xiang, X., Li, S., Yu, J., Qu, K., Xu, Z., Han, P., Dong, Z., Liu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16800374
Zheng, T., Huang, J., Xiang, X., Li, S., Yu, J., Qu, K., Xu, Z., Han, P., Dong, Z., Liu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16800389
Zheng, T., Huang, J., Xiang, X., Li, S., Yu, J., Qu, K., Xu, Z., Han, P., Dong, Z., Liu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16800383
KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1Preprint
Ber, S., Yang, M. H., Sciacovelli, M., Samarajiwa, S., Patel, K., Nikitopoulou, E., Howitt, A., Cook, S. J., Venkitaraman, A. R., Frezza, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.19.618135
Kang, Z., Hong, Q., Yan, F., Yu, T., Bai, Y., Liu, X., Na, X., & Wang, C. (2025) · Frigid Zone Medicine · doi:10.1515/fzm-2025-0004
Su, T., Zhang, X., Sun, Y., Chen, X., Tian, M., Yan, D., Zhao, Y., & Han, B.-J. (2025) · Inorganic Chemistry Frontiers · doi:10.1039/d5qi01088h
Iyer, S., & Schlichtholz, B. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168024 · Cited by 1
Ye, Z., Wu, H., Li, Z., Ye, R., Rao, Y., Liu, B., & Gao, B. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1673513
Li, C., Yuan, Z., Fu, C., Zhao, Q., Zhao, J., & Li, B. (2025) · Discover Oncology · doi:10.1007/s12672-025-03765-9
Metadata
- Authors
- Kim, J., Hu, Z., Cai, L., Li, K., Choi, E., Faubert, B., Bezwada, D., Rodriguez-Canales, J., Villalobos, P., Lin, Y.-F., Ni, M., Huffman, K. E., Girard, L., Byers, L. A., Unsal-Kacmaz, K., Peña, C. G., Heymach, J. V., Wauters, E., Vansteenkiste, J., Castrillon, D. H., Chen, B. P. C., Wistuba, I., Lambrechts, D., Xu, J., Minna, J. D., & DeBerardinis, R. J.
- Affiliations
- Children's Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- KU Leuven (BE)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Corresponding author
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2017-05-24
- Volume
- 546
- Issue
- 7656
- Pages
- 168-172
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5472349
- OpenAlex
- W2619620886
- Cited by
- 325
- References
- 30
- Citations by year
- 2026: 39 · 2025: 40 · 2024: 26 · 2023: 42 · 2022: 38 · 2021: 45 · 2020: 38 · 2019: 26 · 2018: 27 · 2017: 4
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-05-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Funders
- National Cancer Institute (P50CA070907, U01CA176284, R01CA196912, R01CA157996)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK093543, R01DK111430)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- CPS1, LKB1, KRAS mutation, non-small cell lung cancer, lung adenocarcinoma, pyrimidine metabolism, urea cycle, nitrogen metabolism, DNA synthesis, DNA damage, AMPK, tumor metabolic reprogramming, S phase progression, tumor suppressor loss
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Ammonia, Animals, Bicarbonates, Carbamyl Phosphate, Carbamoyl-Phosphate Synthase (Ammonia), Carcinoma, Non-Small-Cell Lung, DNA, DNA Damage, DNA-Directed DNA Polymerase, DNA Replication, Female, Humans, Lung Neoplasms, Male, Mitochondria, Nitrogen, Purines, Pyrimidines, Transcription, Genetic, S Phase, Proto-Oncogene Proteins p21(ras), Cell Death, Protein Serine-Threonine Kinases, Gene Silencing, Xenograft Model Antitumor Assays, Cell Proliferation, Mice, AMP-Activated Protein Kinases, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review